Connie Loizos

Relay Technology Management, a Cambridge, Mass.-based business intelligence software company, has named Marc Krellenstein as CTO. Krellenstein was previous the founder of Lucid Imagination and the former CTO and VP of search and discovery at Elsevier.

A star pediatric surgeon and his UCSF colleagues are rethinking inefficient medical devices, and gaining momentum with their designs.

Moscow-based Maxwell Biotech Venture Fund (MBVF), along with the Russian fund of funds RVC, has invested an undisclosed amount of money in the Russian biotech company Eleventa, which is trying to develop treatments for asthma and other allergic respiratory diseases.

Nick Hanauer, a Seattle-based venture capitalist who was among the first investors in Amazon.com, is among a number of critics of GOP Presidential candidate Mitt Romney--despite his benefiting from economic policies the Republican candidate would likely support were he elected next month.

The growth-stage investor could seek to raise its eighth fund soon

BioSavita, a Plymouth, Michigan company that produces "biosimilar medicines" for patients in partnership with biopharmaceutical companies, has appointed James Kuo as chairman and CEO. Kuo was most recently chair and CEO of Adeona Pharmaceuticals, a publicly traded Michigan biotech company.

In the world of tech startups, where people are usually busy trying to change the world or become a multimillionaire or both, humor isn't as prized a trait as some others. It can definitely come in handy, though, suggest Dhaya Lakshminarayanan and Jon Dick.

According to his LinkedIn profile, Bonnie has just joined Allen & Co. as a managing director in the investment firm’s San Francisco office.

Investors looking to wring returns out of foreign investments would right now do better sticking with stocks than investing through venture capital or private equity funds, suggests new data out of Cambridge Associates.